Compulsory Storage and Distribution Standards in Drug Rules Soon, Draft Rules Released for 30 days Consultation Window

The Ministry of Health and Family Welfare has published draft amendments to the Drugs Rules, 1945 (Notification G.S.R. 984(E), dated November 4, 2026) to legally mandate compliance with Good Distribution Practices (GDP) across India's pharmaceutical supply chain.

Key Highlights

·         Formal Definition Added: Introduces a new sub-rule under Rule 2 defining "Guidelines on Good Storage and Distribution Practices (GSDP) for Pharmaceutical Products" as the standards formulated by the Central Drugs Standard Control Organisation (CDSCO) and adopted by the Drugs Technical Advisory Board (DTAB).

·         Mandatory Compliance Across License Types: Inserts a direct condition requiring licensees to ensure compliance with the Good Distribution Practices Guidelines across multiple licensing categories under the Drugs Rules, 1945:

o    Import Licenses: Rules 26 and 33A

o    Sale & Distribution Licenses: Rule 65

o    Manufacturing & Loan Licenses: Rules 74, 74A, 74B, 78, and 78A

o    Blood Centre / Blood Bank Licenses: Rule 122P

·         Public Consultation Window: The Central Government is inviting objections and suggestions from stakeholders within 30 days from the date the Gazette copies are made available to the public. Feedback can be sent by post to the Under Secretary (Drugs), Ministry of Health and Family Welfare (Kartavya Bhavan 1, New Delhi) or emailed to drugsdiv-mohfw@gov.in.

·         Effective Date: The final rules will come into force on a date specified by the government upon final publication in the Official Gazette.

 

<Notification G.S.R. 984(E), dated November 4, 2026>